SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-006927
Filing Date
2023-03-07
Accepted
2023-03-07 16:30:42
Documents
14
Period of Report
2023-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45343
2 ex10-1.htm EX-10.1 154409
3 ex99-1.htm EX-99.1 15024
  Complete submission text file 0001493152-23-006927.txt   417359

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bstg-20230301.xsd EX-101.SCH 3227
5 XBRL LABEL FILE bstg-20230301_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bstg-20230301_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3280
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 23713020
SIC: 3841 Surgical & Medical Instruments & Apparatus